Phenobarbital induction of drug/steroid-metabolizing enzymes and nuclear receptor CAR

Phenobarbital (PB) increases hepatic drug/steroid-metabolic capability by coordinately activating transcription of the genes encoding various metabolizing enzymes. The nuclear receptor CAR was first implicated as a transcription factor that activates the cytochrome P450 Cyp2b10 gene. In response to...

Full description

Saved in:
Bibliographic Details
Published inBBA - General Subjects Vol. 1619; no. 3; pp. 239 - 242
Main Authors Kakizaki, Satoru, Yamamoto, Yukio, Ueda, Akiko, Moore, Rick, Sueyoshi, Tatsuya, Negishi, Masahiko
Format Book Review Journal Article
LanguageEnglish
Published Netherlands Elsevier B.V 17.02.2003
Subjects
Online AccessGet full text
ISSN0304-4165
0006-3002
1872-8006
DOI10.1016/S0304-4165(02)00482-8

Cover

More Information
Summary:Phenobarbital (PB) increases hepatic drug/steroid-metabolic capability by coordinately activating transcription of the genes encoding various metabolizing enzymes. The nuclear receptor CAR was first implicated as a transcription factor that activates the cytochrome P450 Cyp2b10 gene. In response to PB, CAR forms a heterodimer with the retinoid X receptor (RXR), binds to a PB response element (typified by DR-4 motif), and activates transcription of the gene. In the CAR-null mouse, PB does not only induce the Cyp2b10 gene, but also induces genes encoding various metabolizing enzymes. Thus, CAR is a general nuclear receptor that is essential for PB induction of drug/steroid metabolizing enzymes. PB also induces amino levulinate synthase 1 (ALAS-1), the rate-limiting enzyme in heme biosynthesis, to increase heme supply. However, PB induction of the synthase occurs in CAR-null mice, suggesting that CAR does not coordinate the heme synthesis for the induction of drug/steroid metabolism.
Bibliography:ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
ObjectType-Review-3
content type line 23
ISSN:0304-4165
0006-3002
1872-8006
DOI:10.1016/S0304-4165(02)00482-8